Cost-effectiveness of tuberculosis evaluation and treatment of newly-arrived immigrants
Open Access
- 19 June 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Public Health
- Vol. 6 (1), 157-15
- https://doi.org/10.1186/1471-2458-6-157
Abstract
Background Immigrants to the U.S. are required to undergo overseas screening for tuberculosis (TB), but the value of evaluation and treatment following entry to the U.S. is not well understood. We determined the cost-effectiveness of domestic follow-up of immigrants identified as tuberculosis suspects through overseas screening. Methods Using a stochastic simulation for tuberculosis reactivation, transmission, and follow-up for a hypothetical cohort of 1000 individuals, we calculated the incremental cost-effectiveness of follow-up and evaluation interventions. We utilized published literature, California Reports of Verified Cases of Tuberculosis (RVCTs), demographic estimates from the California Department of Finance, Medicare reimbursement, and Medi-Cal reimbursement rates. Our target population was legal immigrants to the United States, our time horizon is twenty years, and our perspective was that of all domestic health-care payers. We examined the intervention to offer latent tuberculosis therapy to infected individuals, to increase the yield of domestic evaluation, and to increase the starting and completion rates of LTBI therapy with INH (isoniazid). Our outcome measures were the number of cases averted, the number of deaths averted, the incremental dollar cost (year 2004), and the number of quality-adjusted life-years saved. Results Domestic follow-up of B-notification patients, including LTBI treatment for latently infected individuals, is highly cost-effective, and at times, cost-saving. B-notification follow-up in California would reduce the number of new tuberculosis cases by about 6–26 per year (out of a total of approximately 3000). Sensitivity analysis revealed that domestic follow-up remains cost-effective when the hepatitis rates due to INH therapy are over fifteen times our best estimates, when at least 0.4 percent of patients have active disease and when hospitalization of cases detected through domestic follow-up is no less likely than hospitalization of passively detected cases. Conclusion While the current immigration screening program is unlikely to result in a large change in case rates, domestic follow-up of B-notification patients, including LTBI treatment, is highly cost-effective. If as many as three percent of screened individuals have active TB, and early detection reduces the rate of hospitalization, net savings may be expected.Keywords
This publication has 53 references indexed in Scilit:
- Using Cost and Health Impacts to Prioritize the Targeted Testing of Tuberculosis in the United StatesAnnals of Epidemiology, 2006
- Domestic Returns from Investment in the Control of Tuberculosis in Other CountriesThe New England Journal of Medicine, 2005
- Screening and Treatment of Latent Tuberculosis Among Healthcare Workers at Low, Moderate, and High Risk for Tuberculosis Exposure: A Cost-Effectiveness AnalysisInfection Control & Hospital Epidemiology, 2004
- Infectious Tuberculosis among Newly Arrived Refugees in the United StatesThe New England Journal of Medicine, 2004
- Amplification Dynamics: Predicting the Effect of HIV on Tuberculosis OutbreaksJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Universal HIV screening at a major metropolitan TB clinic: HIV prevalence and high-risk behaviors among TB patients.American Journal of Public Health, 1999
- Prospects for worldwide tuberculosis control under the WHO DOTS strategyThe Lancet, 1998
- Overseas Screening for Tuberculosis in Immigrants and Refugees to the United States: Current StatusClinical Infectious Diseases, 1996
- The intrinsic transmission dynamics of tuberculosis epidemicsNature Medicine, 1995
- The utility of different health states as perceived by the general publicJournal of Chronic Diseases, 1978